NCT04882540View on ClinicalTrials.gov

A Study to Evaluate the Pharmacokinetics and Safety of Brivaracetam in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 19, 2021

Primary Completion Date

June 8, 2021

Study Completion Date

June 8, 2021

Conditions
Healthy Participants
Interventions
DRUG

brivaracetam

"* Pharmaceutical form: Film-coated tablets~* Concentration: 100 mg tablets~* Route of administration: Oral use"

Trial Locations (1)

Unknown

Ep0101 101, Shanghai

All Listed Sponsors
lead

UCB Biopharma SRL

INDUSTRY